Management of atrial fibrillation: Figure 1
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterised by uncoordinated atria activation with consequent deterioration of atrial mechanical function. It is the most common arrhythmia encountered in the clinical practice of the developed countries,1w1 and accounts for 1% of all National Health Service expenditure in the United Kingdom.w2 The prevalence and incidence of AF increases with advancing age, affecting approximately 5% of individuals older than 65 years and nearly 10% of those aged older than 80 years.2 So common is this problem that it is expected that more than five million Americans will be living with AF by the year 2050.w1 AF also coexists with common cardiovascular conditions, such as hypertension, heart failure, coronary artery disease and diabetes mellitus, and with an increasingly older general population, AF (and its co-morbidities) will become an increasing health care burden.2w3 w4 Indeed, hospitalisation rates for AF have increased by 2–3 fold.w4 In the Framingham Heart Study, AF was associated with a 1.5- to 1.9-fold mortality risk, even after adjustment for the pre-existing cardiovascular conditions.w5 AF also confers a substantial morbidity from stroke, thromboembolism, heart failure and impaired quality of life; indeed, stroke survivors associated with AF have more severe strokes with greater disability, longer hospital stays and lower rates of discharge to their own home.2 The aim of this review is to provide a practical and clinically useful approach to the management of AF. The current 2001 American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) consensus guidelines1 for the management of patients with AF will be updated in late 2006, and the evidence-based UK National Institute for Health and Clinical Excellence (NICE) guidelines are available (www.nice.org.uk) in their final form from June 2006. The extensive literature on the electrophysiology and …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Inflammation as a risk factor for atrial fibrillation
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103131.70301.4f · Cited by 1,425 · cited 1×
“Inflammation may precede the development of AF and contribute to its persistence.”
BackgroundWazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826
Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., & Connolly, S. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.070 · Cited by 822
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749 · cited 1×
“scheme (an acronym for Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischaemic attack) successfully identified primary prevention patients who were at high risk of stroke (5.3 strokes per 100 patient-years),”
BackgroundInfluentialPopulation prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2001) · Heart · doi:10.1136/heart.86.5.516 · Cited by 661
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627
Hindricks, G., Piorkowski, C., Tanner, H., Kobza, R., Gerds-Li, J.-H., Carbucicchio, C., & Kottkamp, H. (2005) · Circulation · doi:10.1161/circulationaha.104.518837 · Cited by 506 · cited 1×
“Frequently, asymptomatic episodes do occur and may be significantly increased after catheter ablation, especially among previously symptomatic patients—thus, follow-up based on symptoms only would substantially overestimate the success rate of ablation procedures.”
BackgroundOutpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach
Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479 · cited 1×
“In patients with paroxysmal AF who have infrequent paroxysms or few symptoms, or where symptoms are induced by known precipitants (for example, alcohol, caffeine), a “no drug treatment” strategy or a “pill-in-the-pocket” strategy could be considered.”
BackgroundClinical Outcomes After Ablation and Pacing Therapy for Atrial Fibrillation: A Meta-Analysis
Wood, M. A., Brown-Mahoney, C., Kay, G. N., & Ellenbogen, K. A. (2000) · Circulation · doi:10.1161/01.cir.101.10.1138 · Cited by 476
Secular trends in the prevalence of atrial fibrillation: The Framingham study
Wolf, P. A., Benhamin, E. J., Belanger, A. J., Kannel, W. B., Levy, D., & D'Agostino, R. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90288-4 · Cited by 446
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437 · cited 1×
“With such a common and important condition, is it worth screening for AF? This was recently addressed in the SAFE (Screening for Atrial Fibrillation in the agEd) study,”
BackgroundSelf-citationFlaker, G. C., Belew, K., Beckman, K., Vidaillet, H., Kron, J., Safford, R., Mickel, M., & Barrell, P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.032 · Cited by 341
Kinlay, S., Leitch, J. W., Neil, A., Chapman, B. L., Hardy, D. B., & Fletcher, P. J. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_1-199601010-00003 · Cited by 245
Atrial fibrillation and stroke: new ideas, persisting dilemmas
Halperin, J. L., & Hart, R. G. (1988) · Stroke · doi:10.1161/01.str.19.8.937 · Cited by 231
Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00247-1 · Cited by 74
Cited by
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationA sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke
Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., Gulcher, J., Mathiesen, E. B., Njølstad, I., Nyrnes, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.417 · Cited by 489
Hohnloser, S. H., Pajitnev, D., Pogue, J., Healey, J. S., Pfeffer, M. A., Yusuf, S., & Connolly, S. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.076 · Cited by 460
Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke
Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U., Helgadottir, A., Gschwendtner, A., Kostulas, K., Kuhlenbäumer, G., Bevan, S., Jonsdottir, T., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21480 · Cited by 288
Ruiz-Nodar, J. M., Marín, F., Hurtado, J. A., Valencia, J., Pinar, E., Pineda, J., Gimeno, J. R., Sogorb, F., Valdés, M., & Lip, G. Y. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.035 · Cited by 269
Metadata
- Authors
- Lip, G. Y. H., & Tello-Montoliu, A.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2006-07-14
- Volume
- 92
- Issue
- 8
- Pages
- 1177-1182
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2146309000
- Cited by
- 100
- References
- 19
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.